$RGEN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in REPLIGEN CORP.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in REPLIGEN CORP. Get notifications about new insider transactions in REPLIGEN CORP for free.

Page: < prev 1 2 3 4 5 6 7 ... 7 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Aug 24 2018	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Sell	S	51.44	2,366	121,698	4,988	7.4 K to 5 K (-32.17 %)
Aug 13 2018	RGEN	REPLIGEN CORP	EDDLEMAN ROY T	10% Owner	Sell	S	49.54	39,215	1,942,691	370,000	409.2 K to 370 K (-9.58 %)
Aug 13 2018	RGEN	REPLIGEN CORP	EDDLEMAN ROY T	10% Owner	Sell	S	49.67	76,858	3,817,844	720,000	796.9 K to 720 K (-9.65 %)
Aug 08 2018	RGEN	REPLIGEN CORP	EDDLEMAN ROY T	10% Owner	Sell	S	49.05	4,770	233,970	409,215	414 K to 409.2 K (-1.15 %)
Aug 08 2018	RGEN	REPLIGEN CORP	EDDLEMAN ROY T	10% Owner	Sell	S	49.05	16,015	785,577	413,985	430 K to 414 K (-3.72 %)
Aug 08 2018	RGEN	REPLIGEN CORP	EDDLEMAN ROY T	10% Owner	Sell	S	49.05	33,142	1,625,599	796,858	830 K to 796.9 K (-3.99 %)
Jul 30 2018	RGEN	REPLIGEN CORP	EDDLEMAN ROY T	10% Owner	Option Exercise	P	43.89	1	44	1
Jul 30 2018	RGEN	REPLIGEN CORP	EDDLEMAN ROY T	10% Owner	Option Exercise	S	53.94	1	54	1
Jul 20 2018	RGEN	REPLIGEN CORP	Snodgres Jon	CFO	Payment of Exercise	F	47.91	295	14,134	35,359	35.7 K to 35.4 K (-0.83 %)
Jul 16 2018	RGEN	REPLIGEN CORP	EDDLEMAN ROY T	10% Owner	Option Exercise	P	43.50	1	43	1
Jul 16 2018	RGEN	REPLIGEN CORP	EDDLEMAN ROY T	10% Owner	Option Exercise	S	54.93	1	55	1
Jun 21 2018	RGEN	REPLIGEN CORP	EDDLEMAN ROY T	10% Owner	Gift	G	0.00	22,530	0	2,903,446	2.9 M to 2.9 M (-0.77 %)
Jun 21 2018	RGEN	REPLIGEN CORP	EDDLEMAN ROY T	10% Owner	Gift	G	0.00	22,530	0	2,903,446	2.9 M to 2.9 M (-0.77 %)
May 22 2018	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	42.53	16,249	691,016	243,144	259.4 K to 243.1 K (-6.26 %)
May 18 2018	RGEN	REPLIGEN CORP	EDDLEMAN ROY T	10% Owner	Sell	S	42.07	118,850	5,000,020	2,925,976	3 M to 2.9 M (-3.90 %)
May 17 2018	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Option Exercise	A	42.07	3,304	138,999	3,304
May 17 2018	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Grant	A	0.00	1,486	0	9,286	7.8 K to 9.3 K (+19.05 %)
May 17 2018	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Gift	G	0.00	900	0	7,800	8.7 K to 7.8 K (-10.34 %)
May 17 2018	RGEN	REPLIGEN CORP	MUIR GLENN P	Director	Option Exercise	A	42.07	3,304	138,999	3,304
May 17 2018	RGEN	REPLIGEN CORP	MUIR GLENN P	Director	Grant	A	0.00	1,486	0	4,455	3 K to 4.5 K (+50.05 %)
May 17 2018	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	A	42.07	4,626	194,616	4,626
May 17 2018	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Grant	A	0.00	2,080	0	97,037	95 K to 97 K (+2.19 %)
May 17 2018	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	A	42.07	3,304	138,999	3,304
May 17 2018	RGEN	REPLIGEN CORP	Cox John	Director	Grant	A	0.00	1,486	0	6,313	4.8 K to 6.3 K (+30.79 %)
May 17 2018	RGEN	REPLIGEN CORP	COOPER GLENN L MD	Director	Option Exercise	A	42.07	3,304	138,999	3,304
May 17 2018	RGEN	REPLIGEN CORP	COOPER GLENN L MD	Director	Grant	A	0.00	1,486	0	39,786	38.3 K to 39.8 K (+3.88 %)
May 17 2018	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Option Exercise	A	42.07	3,304	138,999	3,304
May 17 2018	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Grant	A	0.00	1,486	0	6,340	4.9 K to 6.3 K (+30.61 %)
May 15 2018	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	M	5.08	20,000	101,600	0
May 15 2018	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	41.80	20,000	835,936	94,957	115 K to 95 K (-17.40 %)
May 15 2018	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Buy	M	5.08	20,000	101,600	114,957	95 K to 115 K (+21.06 %)
May 11 2018	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Option Exercise	M	26.12	3,366	87,920	0
May 11 2018	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Option Exercise	M	20.37	24,000	488,880	0
May 11 2018	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Sell	S	40.54	26,500	1,074,238	4,854	31.4 K to 4.9 K (-84.52 %)
May 11 2018	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Buy	M	26.12	3,366	87,920	31,354	28 K to 31.4 K (+12.03 %)
May 11 2018	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Buy	M	20.37	24,000	488,880	27,988	4 K to 28 K (+601.81 %)
May 11 2018	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Payment of Exercise	F	40.70	1,400	56,980	259,393	260.8 K to 259.4 K (-0.54 %)
May 09 2018	RGEN	REPLIGEN CORP	EDDLEMAN ROY T	10% Owner	Sell	S	40.37	25,000	1,009,250	850,000	875 K to 850 K (-2.86 %)
May 09 2018	RGEN	REPLIGEN CORP	EDDLEMAN ROY T	10% Owner	Sell	S	40.52	20,773	841,722	410,000	430.8 K to 410 K (-4.82 %)
May 09 2018	RGEN	REPLIGEN CORP	EDDLEMAN ROY T	10% Owner	Sell	S	40.66	25,000	1,016,500	875,000	900 K to 875 K (-2.78 %)
May 09 2018	RGEN	REPLIGEN CORP	EDDLEMAN ROY T	10% Owner	Sell	S	40.77	49,227	2,006,985	430,773	480 K to 430.8 K (-10.26 %)
Mar 12 2018	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Option Exercise	M	18.12	3,696	66,972	0
Mar 12 2018	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Option Exercise	M	3.22	1,000	3,220	0
Mar 12 2018	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Sell	S	36.16	4,696	169,792	8,700	13.4 K to 8.7 K (-35.06 %)
Mar 12 2018	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Buy	M	18.12	3,696	66,972	13,396	9.7 K to 13.4 K (+38.10 %)
Mar 12 2018	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Buy	M	3.22	1,000	3,220	9,700	8.7 K to 9.7 K (+11.49 %)
Mar 05 2018	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Option Exercise	A	33.87	12,850	435,230	12,850
Mar 05 2018	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Grant	A	0.00	6,643	0	12,605	6 K to 12.6 K (+111.42 %)
Mar 05 2018	RGEN	REPLIGEN CORP	Snodgres Jon	CFO	Option Exercise	A	33.87	20,659	699,720	20,659
Mar 05 2018	RGEN	REPLIGEN CORP	Snodgres Jon	CFO	Grant	A	0.00	10,680	0	35,654	25 K to 35.7 K (+42.76 %)
Mar 05 2018	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Option Exercise	A	33.87	285,563	9,672,019	285,563
Mar 05 2018	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Option Exercise	A	33.87	74,246	2,514,712	74,246
Mar 05 2018	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Grant	A	0.00	147,623	0	260,793	113.2 K to 260.8 K (+130.44 %)
Mar 05 2018	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Grant	A	0.00	38,382	0	113,170	74.8 K to 113.2 K (+51.32 %)
Mar 02 2018	RGEN	REPLIGEN CORP	Snodgres Jon	CFO	Payment of Exercise	F	35.16	2,470	86,843	24,974	27.4 K to 25 K (-9.00 %)
Mar 02 2018	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Payment of Exercise	F	34.91	8,825	308,051	74,788	83.6 K to 74.8 K (-10.55 %)
Jan 24 2018	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	35.95	8,970	322,445	83,613	92.6 K to 83.6 K (-9.69 %)
Dec 28 2017	RGEN	REPLIGEN CORP	EDDLEMAN ROY T	10% Owner	Gift	G	0.00	900,000	0	357,518	1.3 M to 357.5 K (-71.57 %)
Dec 28 2017	RGEN	REPLIGEN CORP	EDDLEMAN ROY T	10% Owner	Gift	G	0.00	480,000	0	357,518	837.5 K to 357.5 K (-57.31 %)
Dec 18 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Option Exercise	M	26.05	4,062	105,815	8,124
Dec 18 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Option Exercise	M	26.20	6,021	157,750	3,010
Dec 18 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Option Exercise	M	15.91	2,646	42,098	0
Dec 18 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Sell	S	35.34	12,729	449,835	33,908	46.6 K to 33.9 K (-27.29 %)
Dec 18 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Buy	M	26.05	4,062	105,815	46,637	42.6 K to 46.6 K (+9.54 %)
Dec 18 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Buy	M	26.20	6,021	157,750	42,575	36.6 K to 42.6 K (+16.47 %)
Dec 18 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Buy	M	15.91	2,646	42,098	36,554	33.9 K to 36.6 K (+7.80 %)
Jul 20 2017	RGEN	REPLIGEN CORP	Snodgres Jon	CFO	Payment of Exercise	F	41.77	345	14,411	27,444	27.8 K to 27.4 K (-1.24 %)
May 22 2017	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Option Exercise	A	38.76	2,434	94,342	2,434
May 22 2017	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Grant	A	0.00	1,206	0	8,700	7.5 K to 8.7 K (+16.09 %)
May 22 2017	RGEN	REPLIGEN CORP	MUIR GLENN P	Director	Option Exercise	A	38.76	2,434	94,342	2,434
May 22 2017	RGEN	REPLIGEN CORP	MUIR GLENN P	Director	Grant	A	0.00	1,206	0	2,969	1.8 K to 3 K (+68.41 %)
May 22 2017	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	A	38.76	2,434	94,342	2,434
May 22 2017	RGEN	REPLIGEN CORP	Cox John	Director	Grant	A	0.00	1,206	0	4,827	3.6 K to 4.8 K (+33.31 %)
May 22 2017	RGEN	REPLIGEN CORP	COOPER GLENN L MD	Director	Option Exercise	A	38.76	2,434	94,342	2,434
May 22 2017	RGEN	REPLIGEN CORP	COOPER GLENN L MD	Director	Grant	A	0.00	1,206	0	38,300	37.1 K to 38.3 K (+3.25 %)
May 22 2017	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Option Exercise	A	38.76	2,434	94,342	2,434
May 22 2017	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Grant	A	0.00	1,206	0	3,988	2.8 K to 4 K (+43.35 %)
May 22 2017	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	A	38.76	3,459	134,071	3,459
May 22 2017	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Grant	A	0.00	1,714	0	94,957	93.2 K to 95 K (+1.84 %)
May 11 2017	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Payment of Exercise	F	37.97	2,275	86,393	92,583	94.9 K to 92.6 K (-2.40 %)
Mar 31 2017	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Gift	G	0.00	350	0	7,494	7.8 K to 7.5 K (-4.46 %)
Mar 31 2017	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Gift	G	0.00	750	0	7,844	8.6 K to 7.8 K (-8.73 %)
Mar 22 2017	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	M	4.29	20,000	85,800	0
Mar 22 2017	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	34.12	2,521	86,017	93,243	95.8 K to 93.2 K (-2.63 %)
Mar 22 2017	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Buy	M	4.29	20,000	85,800	95,764	75.8 K to 95.8 K (+26.40 %)
Mar 22 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Option Exercise	M	6.23	10,000	62,300	0
Mar 22 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Option Exercise	M	15.91	4,968	79,041	0
Mar 22 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Buy	M	6.23	10,000	62,300	33,908	23.9 K to 33.9 K (+41.83 %)
Mar 22 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Sell	S	34.63	7,248	251,010	23,908	31.2 K to 23.9 K (-23.26 %)
Mar 22 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Sell	S	34.61	4,968	171,944	31,156	36.1 K to 31.2 K (-13.75 %)
Mar 22 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Buy	M	15.91	4,968	79,041	36,124	31.2 K to 36.1 K (+15.95 %)
Mar 22 2017	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Option Exercise	M	3.22	4,000	12,880	1,000
Mar 22 2017	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Sell	S	34.83	4,000	139,321	8,594	12.6 K to 8.6 K (-31.76 %)
Mar 22 2017	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Buy	M	3.22	4,000	12,880	12,594	8.6 K to 12.6 K (+46.54 %)
Mar 21 2017	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Option Exercise	M	24.50	4,000	98,000	6,000
Mar 21 2017	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Buy	M	24.50	4,000	98,000	27,789	23.8 K to 27.8 K (+16.81 %)
Mar 21 2017	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Sell	S	34.91	1,909	66,646	23,789	25.7 K to 23.8 K (-7.43 %)
Mar 01 2017	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Option Exercise	A	32.32	19,750	638,320	19,750
Mar 01 2017	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Payment of Exercise	F	32.07	1,630	52,273	25,698	27.3 K to 25.7 K (-5.96 %)
Mar 01 2017	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Grant	A	0.00	9,875	0	27,328	17.5 K to 27.3 K (+56.58 %)
Mar 01 2017	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Option Exercise	A	32.32	64,975	2,099,992	64,975
Mar 01 2017	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Payment of Exercise	F	32.07	5,972	191,524	94,858	100.8 K to 94.9 K (-5.92 %)
Mar 01 2017	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Grant	A	0.00	32,488	0	100,830	68.3 K to 100.8 K (+47.54 %)
Mar 01 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Option Exercise	A	32.32	9,012	291,268	9,012
Mar 01 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Payment of Exercise	F	32.08	1,976	63,387	31,156	33.1 K to 31.2 K (-5.96 %)
Mar 01 2017	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Grant	A	0.00	4,506	0	33,132	28.6 K to 33.1 K (+15.74 %)
Nov 29 2016	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	33.12	5,000	165,613	68,342	73.3 K to 68.3 K (-6.82 %)
Sep 16 2016	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Sell	S	32.58	2,700	87,979	9,394	12.1 K to 9.4 K (-22.33 %)
Jul 15 2016	RGEN	REPLIGEN CORP	Snodgres Jon	CFO	Payment of Exercise	F	26.56	324	8,605	17,453	17.8 K to 17.5 K (-1.82 %)
Jul 15 2016	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Grant	A	0.00	20,000	0	75,764	55.8 K to 75.8 K (+35.87 %)
Jul 01 2016	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Sell	S	26.60	5,000	133,010	12,094	17.1 K to 12.1 K (-29.25 %)
Jun 29 2016	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Option Exercise	M	3.22	5,000	16,100	5,000
Jun 29 2016	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Option Exercise	M	3.22	5,000	16,100	5,000
Jun 29 2016	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Sell	S	24.59	10,000	245,888	17,094	27.1 K to 17.1 K (-36.91 %)
Jun 29 2016	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Sell	S	24.59	10,000	245,888	17,094	27.1 K to 17.1 K (-36.91 %)
Jun 29 2016	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Buy	M	3.22	5,000	16,100	27,094	22.1 K to 27.1 K (+22.63 %)
Jun 29 2016	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Buy	M	3.22	5,000	16,100	27,094	22.1 K to 27.1 K (+22.63 %)
Jun 28 2016	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	M	3.10	15,000	46,500	0
Jun 28 2016	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	M	3.10	15,000	46,500	0
Jun 28 2016	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Payment of Exercise	F	23.46	1,982	46,498	55,764	57.7 K to 55.8 K (-3.43 %)
Jun 28 2016	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Payment of Exercise	F	23.46	1,982	46,498	55,764	57.7 K to 55.8 K (-3.43 %)
Jun 28 2016	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Buy	M	3.10	15,000	46,500	57,746	42.7 K to 57.7 K (+35.09 %)
Jun 28 2016	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Buy	M	3.10	15,000	46,500	57,746	42.7 K to 57.7 K (+35.09 %)
May 26 2016	RGEN	REPLIGEN CORP	Benjamin Howard		Option Exercise	M	6.23	10,000	62,300	10,000
May 26 2016	RGEN	REPLIGEN CORP	Benjamin Howard		Buy	M	6.23	10,000	62,300	28,626	18.6 K to 28.6 K (+53.69 %)
May 13 2016	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Option Exercise	A	26.12	3,366	87,920	3,366
May 13 2016	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Grant	A	0.00	1,763	0	22,094	20.3 K to 22.1 K (+8.67 %)
May 13 2016	RGEN	REPLIGEN CORP	MUIR GLENN P	Director	Option Exercise	A	26.12	3,366	87,920	3,366
May 13 2016	RGEN	REPLIGEN CORP	MUIR GLENN P	Director	Grant	A	0.00	1,763	0	1,763	0 to 1.8 K
May 13 2016	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	A	26.12	3,366	87,920	3,366
May 13 2016	RGEN	REPLIGEN CORP	Cox John	Director	Grant	A	0.00	1,763	0	3,621	1.9 K to 3.6 K (+94.89 %)
May 13 2016	RGEN	REPLIGEN CORP	COOPER GLENN L MD	Director	Option Exercise	A	26.12	3,366	87,920	3,366
May 13 2016	RGEN	REPLIGEN CORP	COOPER GLENN L MD	Director	Grant	A	0.00	1,763	0	37,094	35.3 K to 37.1 K (+4.99 %)
May 13 2016	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Option Exercise	A	26.12	3,366	87,920	3,366
May 13 2016	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Grant	A	0.00	1,763	0	2,782	1 K to 2.8 K (+173.01 %)
May 13 2016	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	A	26.12	4,783	124,932	4,783
May 13 2016	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Grant	A	0.00	2,505	0	42,746	40.2 K to 42.7 K (+6.22 %)
May 13 2016	RGEN	REPLIGEN CORP	Benjamin Howard		Sell	S	26.72	2,889	77,199	18,626	21.5 K to 18.6 K (-13.43 %)
May 09 2016	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Payment of Exercise	F	25.71	1,622	41,702	73,342	75 K to 73.3 K (-2.16 %)
Mar 01 2016	RGEN	REPLIGEN CORP	RUSCHE JAMES R	Senior Vice Preside ...	Option Exercise	A	26.05	9,895	257,765	9,895
Mar 01 2016	RGEN	REPLIGEN CORP	RUSCHE JAMES R	Senior Vice Preside ...	Payment of Exercise	F	26.05	1,419	36,965	100,516	101.9 K to 100.5 K (-1.39 %)
Mar 01 2016	RGEN	REPLIGEN CORP	RUSCHE JAMES R	Senior Vice Preside ...	Grant	A	0.00	5,086	0	101,935	96.8 K to 101.9 K (+5.25 %)
Mar 01 2016	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Option Exercise	A	26.05	12,186	317,445	12,186
Mar 01 2016	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Payment of Exercise	F	26.05	1,302	33,917	21,515	22.8 K to 21.5 K (-5.71 %)
Mar 01 2016	RGEN	REPLIGEN CORP	Benjamin Howard	VP Business Develop ...	Grant	A	0.00	6,263	0	22,817	16.6 K to 22.8 K (+37.83 %)
Mar 01 2016	RGEN	REPLIGEN CORP	Snodgres Jon	CFO	Option Exercise	A	26.05	15,380	400,649	15,380
Mar 01 2016	RGEN	REPLIGEN CORP	Snodgres Jon	CFO	Payment of Exercise	F	26.05	748	19,485	17,777	18.5 K to 17.8 K (-4.04 %)
Mar 01 2016	RGEN	REPLIGEN CORP	Snodgres Jon	CFO	Grant	A	0.00	7,905	0	18,525	10.6 K to 18.5 K (+74.44 %)
Mar 01 2016	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Option Exercise	A	26.05	65,351	1,702,394	65,351
Mar 01 2016	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Payment of Exercise	F	26.05	2,267	59,055	74,964	77.2 K to 75 K (-2.94 %)

Page: < prev 1 2 3 4 5 6 7 ... 7 next >